Read + Share
Ejiofor LCK, Mathiesen IHM, Jensen-Fangel S, Olesen HV, et al. Patients with cystic fibrosis and advanced lung disease benefit from
lumacaftor/ivacaftor treatment. Pediatr Pulmonol 2020;55:3364-3370.
PMID: 32897653
|
 |
|
Ejiofor LCK, Mathiesen IHM, Jensen-Fangel S, Olesen HV, et al. Patients with cystic fibrosis and advanced lung disease benefit from
lumacaftor/ivacaftor treatment. Pediatr Pulmonol 2020;55:3364-3370.
PMID: 32897653
|
|
|
|